BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...

In a breakthrough for cancer care in Nigeria, Biologix Laboratories limited, a wholly owned subsidiary of Biologix Support ...

“With newer advances, cancer care has definitely reached a point where it is no longer a threat to life, but a journey that ...

MVZ HPH Institute for Pathology and Hematopathology GmbH, today announced the availability of HPH MRD, a new tumor-informed ...

More Than Half of Cancers Detected by Galleri Were Early Stage Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended Screenings ...

SYMPLIFY, a prospective observational study, is the first large-scale evaluation of a multi-cancer early detection (MCED) test in individuals who presented with symptoms to primar ...

In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form—but instead of fueling ...

In the histology-centric world of cancer medicine, further work is needed to increase genomic testing rates and educate ...

Biomarkers are pivotal for confirming diagnoses, predicting disease progression, and tailoring therapeutic modalities. Recent ...

Scalable, workflow-optimized solutions will be essential to improving cancer care in emerging and previously underserved ...